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ABSTRACT 19 
Objective: To study the effect on endometrial and endometriotic cells after co-culture 20 
with macrophages, using clonogenic, invasion and self-renewal assays. 21 
Materials and Methods: Peripheral blood samples, endometrium and endometriotic 22 
tissues were collected. Autologous macrophages were co-cultured with endometrial 23 
and endometriotic cells. The number of colony forming units (CFU), invasiveness and 24 
self-renewal activity after co-culture with macrophages was determined. The cytokine 25 
level of colony stimulating factor-1 (CSF-1) from macrophages with and without 26 
endometriosis was compared. 27 
Results: Co-culture with macrophages significantly increased the clonogenic and 28 
invasion ability of endometriotic stromal cells in vitro. Colony stimulating factor-1 29 
(CSF-1) was up-regulated in endometriotic macrophages conditioned medium when 30 
compared to those without the disease. 31 
Conclusions: These data suggest that macrophages may increase the proliferation and 32 
invasion activity of stromal clonogenic cells in women with endometriosis. 33 
34 
 
 
INTRODUCTION 35 
Endometriosis is the presence of endometrial tissue growth outside the uterine cavity 36 
and is a benign gynecological disease affecting ~5% of women of reproductive age 37 
(1). The sex steroid dependent growth of ectopic endometrial tissues may result in 38 
cyclical pelvic pain and infertility. Several proposed theories have implicated the 39 
pathogenesis of endometriosis, including retrograde menstruation, peritoneal cell 40 
metaplasia, genetic predisposition, and altered immunological surveillance (2). The 41 
emerging evidence of somatic stem cells in the human endometrium provides an 42 
alternate candidate cell source for the development of endometriosis (3). 43 
The physiological role of stem cells in the endometrium is to maintain the cyclical 44 
regeneration of the tissue that occurs after each menstruation. Endometrial epithelial 45 
and stromal cells with high clonogenic activity are initiated by stem/progenitor cells 46 
(4). The percentage of clonogenic cells in human endometrium does not vary 47 
significantly across the menstrual cycle (5). Occasional shedding of endometrial stem 48 
cells with colony-forming  potential can reach ectopic sites through retrograde 49 
menstruation, invading the peritoneum to generate endometriotic lesions (6). Studies 50 
examining the eutopic endometrium of women with and without endometriosis 51 
revealed striking differences in gene expression that may predispose some women to 52 
disease development (7-9). Eutopic endometrial stem cells from women with 53 
endometriosis exhibit progesterone resistance which is inherited by their progenies 54 
(10). The uncontrolled growth of ectopic endometrial tissue invades the adjacent 55 
tissues and is associated with neovascularization and local inflammatory responses. 56 
Aberrant production of cytokines and growth, adhesion and angiogenic factors are 57 
linked to the occurrence and maintenance of endometriosis (11). How the changes in 58 
 
 
the inflammatory peritoneal environment influence the behavior of ectopic 59 
endometrial stem cells is unknown.  60 
Pathogenesis of endometriosis is associated with dysfunctional regulation of the 61 
immune system (12), in particular, an increase in macrophages and impairment of 62 
their phagocytic activities (13, 14). Hypoxia and tissue stress recruit peripheral 63 
macrophages to the endometriotic sites and contribute to the lesion’s neovasculature, 64 
sustaining the survival of endometrial cells at the ectopic locations. Chemokines 65 
produced by stromal cells have a significant role in the infiltration of macrophages 66 
into the peritoneal cavity (15, 16).  Activation of macrophages is characterized by 67 
their secretion of a wide variety of cytokines and growth factors (17). Levels of 68 
peritoneal cytokines differ greatly between women with and without endometriosis 69 
(18, 19), and higher amounts of cytokines are detected in advanced stages of the 70 
disease (20).  71 
Little is known about the interactions of macrophages with endometrial colony-72 
forming cells. Here we described the clonal analysis of endometrial and endometriotic 73 
cells after co-culture with macrophages and examined how it affects the cell’s 74 
functional activities.   75 
 76 
MATERIALS AND METHODS 77 
Human Tissue Samples 78 
Two types of endometrial tissues were collected: 1) endometrium from women 79 
without endometriosis (normal endometrium) and 2) ovarian endometrioma 80 
(endometriosis). Endometrial samples (n = 33) were collected from ovulating women 81 
 
 
(45.5 ± 0.5 years) undergoing hysterectomy for leiomyoma or adenomyosis. Cyst 82 
walls of ovarian endometrioma (n = 32) were collected from women (39.3 ± 1.3 years) 83 
undergoing ovarian cystectomy. Only women who had not taken exogenous hormones 84 
for three months before surgery were included. Informed written consent was 85 
obtained from each patient and ethical approval was obtained from the Cluster 86 
Research Ethics Committee/Institutional Review Board of the University of Hong 87 
Kong/Hong Kong West Cluster, Hospital Authority, Hong Kong.  88 
The stage of the menstrual cycle was categorized into proliferative (endometrium, n = 89 
19; endometriotic, n = 16) and secretory (endometrium, n = 14; endometriotic, n = 16 90 
). The samples were dated based on the reported day of the last menses and histology 91 
examination by histopathologists (21). Endometriosis was staged according to the 92 
1996 revised classification of the American Society for Reproductive Medicine (22).  93 
Full thickness endometrial tissue samples or ovarian endometriotic cysts were 94 
collected in Dulbecco’s modified Eagle’s medium/Hams F-12 (DMEM/F-12; Life 95 
technologies, CA, USA) containing 1% antibiotic (Gibco, MD, USA) and 5% fetal 96 
bovine serum (FBS, Gibco). The samples were stored at 4oC and processed within 24 97 
h. 98 
 99 
Isolation of Endometrial and Endometriotic Cells  100 
Human endometrial and endometriotic tissues were digested to single-cell suspensions 101 
using collagenase type I (300 µg/mL, Worthington Biochemical Corp, NJ, USA) and 102 
deoxyribonuclease type I (40 µg/mL, Worthington Biochemical Corp) as described 103 
(23). Red blood cells were removed using Ficoll-Paque (GE Healthcare, Uppsala, 104 
Sweden) density-gradient centrifugation. Leukocytes were eliminated using anti-105 
CD45 antibody-coated Dynabeads (Life Technologies). Purified epithelial cell 106 
 
 
suspensions were separated from stromal cells by using anti-CD368 (EpCAM) 107 
antibody-coated microbeads (Miltenyi Biotec Inc. CA, USA).  108 
 109 
Macrophage Differentiation and Collection of Conditioned Medium 110 
Peripheral blood mononuclear cells from women with and without endometriosis 111 
were isolated with Ficoll-Plaque. Blood samples were collected on the same day as 112 
the endometrial or endometriotic tissue. Monocytes were enriched by the Monocyte 113 
Isolation Kit II (Miltenyi Biotec Inc., CA, USA) and subsequently differentiated into 114 
macrophages in vitro according to previous method (24).  115 
Monocytes were stimulated with phorbol-12 myristate 13-acetate (PMA, 50 ng/ml, 116 
Sigma-Aldrich, MO, USA) in RPMI 1640 medium (Life Technologies), 10% FBS 117 
and 1% penicillin. Differentiation of the monocytes to macrophages was confirmed by 118 
morphological changes such as increase in cell size, formation of pseudopodia and 119 
adhesion (Supplementary data Fig S1A) and by flow cytometry detection of 120 
expression of a macrophage marker CD68 using fluorescein isothiocyanate (FITC) 121 
conjugated anti-CD68 antibody (eBioscience, CA, USA) (Supplementary data Fig 122 
S1B). To determine the phenotype of macrophages, the cells were co-stained with 123 
FITC conjugated anti CD68 (eBioscience) and classical M1 marker allophycocyanin 124 
(APC) conjugated anti-CD86 antibody (BD Biosciences) or alternative M2 marker 125 
APC conjugated anti-CD206 antibody (eBioscience). Cells were analyzed using a 126 
Fortessa flow cytometer (BD Biosciences, CA, USA) in the University of Hong Kong 127 
Core Facility. Macrophages were cultured in 6-well transwells (2 x 105 cells/well, 128 
EMD Millipore) and 72 h after differentiation, the cells were washed with PBS twice 129 
and replaced with RPMI and 1% penicillin. The conditioned media (CM) from 130 
macrophages of women with or without endometriosis were collected 48 h later, 131 
 
 
centrifuged to remove cellular debris and used for subsequent experiment or stored at 132 
-80oC until use.  133 
 134 
Co-culture Setup and Colony-Forming Assay 135 
Six different co-cultures were set up: 1) endometrial epithelial cells co-cultured with 136 
autologous macrophages and CM (n = 4); 2) endometrial stromal cells co-cultured 137 
with autologous macrophages and CM (n = 8); 3) endometriotic epithelial cells co-138 
cultured with autologous macrophages and CM (n=8); 4) endometriotic stromal cells 139 
co-cultured with autologous macrophages and their CM (n=13); 5) endometriotic 140 
epithelial cells co-cultured with macrophages (without endometriosis) and their CM 141 
(n = 3) and 6) endometriotic stromal cells co-cultured with macrophages (without 142 
endometriosis) and their CM (n=3). In brief, cells were seeded in duplicate at a clonal 143 
density of 500 cells/cm2 in 6-well plates (BD Bioscience) and were 1) cultured in 144 
growth medium only (control), 2) cultured in growth medium supplemented with 50 145 
ng/ml PMA (negative control), 3) co-cultured indirectly with macrophages with 50 146 
ng/ml PMA (2 x 105 cells) or, 4) treated with macrophage CM, which was diluted 147 
with growth medium at a ratio of 3:7 (v/v). We supplemented PMA to maintain 148 
macrophages differentiation in long-term culture. The medium was changed every 7 149 
days, and the colonies formed were regularly monitored using an Eclipse TS100 150 
inverted microscope (Nikon). Endometrial cells were cultured for 15 days (4, 25). 151 
Endometriotic cells were cultured for 21 days (23). The colonies formed were fixed 152 
with 10% formalin and stained with 1% Toluidine Blue (Sigma-Aldrich) 153 
(Supplementary data S2A). Colony-forming units (CFUs) consisting of ≥50 cells were 154 
counted to determine the cloning efficiency (CE), which was the percentage of 155 
 
 
colonies formed per seeded cell. Large CFUs were defined as colonies with ≥4,000 156 
cells and small CFUs were those with 4,000 cells as described (23).  157 
 158 
Cell Invasion  159 
Clonally derived endometrial and endometriotic cells were harvested from different 160 
conditions, and 2 x 105 cells were seeded on Matrigel-coated transwells (24 wells, 161 
8µm pore size, BD Biosciences). After 48 h, cells on the upper surface of the inset 162 
membrane were removed with cotton rods, while cells on the lower surface of the 163 
membrane were fixed in 4% paraformaldehyde and stained with 0.1% toluidine blue 164 
(Supplementary data S2B). The transwells were washed and the invaded cells were 165 
lysed with 10% acetic acid. Absorbance of the lysate was measured at 595 nm using a 166 
microplate reader (Tecan). Relative invasion was determined by normalization to the 167 
control group. 168 
 169 
In Vitro Serial Cloning 170 
Individual large epithelial and stromal CFUs from passage 1 (P1) were trypsinized 171 
using cloning rings (Sigma-Aldrich) to determine the self-renewal capacity of cells 172 
from endometrial and endometriotic cells grown in growth medium and co-cultured 173 
with autologous macrophages. A total of three individual large CFUs per patient 174 
sample (n = 3) obtained from the clonogenic assays were used. The cell number of 175 
each CFU was determined and the cells were re-seeded at a density of 20 cells/cm2 176 
(26). This process continued until the cells could no longer form CFUs 177 
(Supplementary data S2). 178 
 
 
 179 
Cytokine Array and ELISA 180 
Cytokine Array C3 (RayBiotech Inc., GA, USA) was used to determine the cytokines 181 
in the macrophage CM from women with endometriosis (n = 6; proliferative n = 3, 182 
secretory n=3) and without endometriosis (n = 6; proliferative n = 3, secretory n=3). 183 
The signal intensities of the cytokines were quantified using Quantity One software 184 
(Bio-Rad, CA, USA, Supplementary Data S5). The CSF-1 level was determined using 185 
enzyme-linked immunosorbent assay (ELISA) (R&D Systems, MN, USA) from 186 
women with endometriosis (n = 11; proliferative n = 5, secretory n = 6) and without 187 
endometriosis (n = 9; proliferative n = 5, secretory n = 4). Each sample was measured 188 
in duplicate. Recombinant CSF-1 (Peprotech, NJ, USA) at 30, 300, and 3000 pg/ml 189 
was added to the growth medium of endometrial and endometriotic stromal cells 190 
seeded at clonal density (500 cells/cm2) for 15 days. For neutralization assay, the anti-191 
human colony stimulating factor (CSF-1) monoclonal antibody (10 µg/ml, Peprotech) 192 
was added to the endometrial epithelial and stromal cells co-cultured with 193 
macrophages and CM without endometriosis. 194 
Flow Cytometry Analysis  195 
The co-expression of CD140b and CD146 on endometrial stromal cells after 15 days 196 
of culture in different conditions (n = 5) were analyzed by multicolour flow cytometry 197 
as described (26). The cells were incubated with FITC-conjugated anti-CD146 (1 198 
mg/ml, OJ79c clone, mouse IgG1; Thermo Fisher Scientific, MA, USA) and PE-199 
conjugated anti-PDGFRβ (CD140b, 2.5 µg/ml, PR7212 clone, Mouse IgG1, R&D 200 
Systems) antibodies in the dark for 45 minutes on ice. Isotype matched controls were 201 
included for each antibody. Following the final washing step, the labeled cells were 202 
 
 
analyzed by Fortessa flow cytometer (BD Biosciences) in the University of Hong 203 
Kong Faculty Core Facility. The cells were selected with electronic gating according 204 
to the forward and side scatter profiles (Supplementary Data S3A-D) using the 205 
FACSDIVA software (BD Biosciences). Data were analyzed using the FlowJo 206 
Software (Tree star Inc.). 207 
Statistical Analysis 208 
Data were analyzed using GraphPad PRISM software (version 5; GraphPad Software 209 
Inc., CA, USA). The normal distribution of the data was determined by the 210 
D’Agostino-Pearson test. The data were analyzed by a non-parametric one-way 211 
ANOVA using Kruskal-Wallis test in multiple groups or using Mann-Whitney test in 212 
case of two groups. Differences of P<0.05 were considered statistically significant.  213 
 214 
RESULTS 215 
Clonogenicity of Human Endometrial and Endometriotic Cells in Co-culture 216 
with Autologous Macrophages 217 
Autologous macrophages or their CM were co-cultured with the endometrial and 218 
endometriotic cells. Since PMA was used to induce macrophages differentiation, cells 219 
treated with PMA alone served as a negative control. To maintain macrophage 220 
differentiation in long-term culture, PMA was also supplemented into the co-culture 221 
treatment. The total CE (large and small colonies) was 0.33 ± 0.17% for endometrial 222 
epithelial cells (Fig 1A). Treatment with macrophages or their CM did not change the 223 
total CE of epithelial cells. There was no difference in the CEs of large endometrial 224 
 
 
epithelial colonies between groups treated with PMA, macrophages or macrophage 225 
CM when compared to the untreated control.  226 
For endometrial stromal cells, the total CE (large and small colonies) was 0.31 ± 227 
0.10% (Fig 1B). Treatment with macrophages or their CM did not change the total CE 228 
of stromal cells. Interestingly, endometrial stromal cells co-cultured with 229 
macrophages (0.23 ± 0.08%) produced significantly more large colonies than stromal 230 
cells alone (0.06 ± 0.03%, P<0.05). Macrophage CM had no effect on the clonogenic 231 
growth of the large stromal colonies. The CEs of endometrial stromal small CFUs 232 
were similar in all conditions. 233 
The overall clonogenicity displayed by endometriotic cells was lower. For 234 
endometriotic epithelial cells, there was significant increase in the total CE between 235 
the PMA (0.01 ± 0.01%) and the macrophage co-culture (0.14 ± 0.05%, P<0.05, Fig 236 
2A) group. The proportion of large epithelial clones in the macrophage (0.13 ± 0.05%) 237 
and the macrophage CM (0.07 ± 0.03%) treated groups were significantly higher than 238 
that of the control (0.003 ± 0.002%, P<0.05). No difference was detected for the 239 
endometriotic epithelial small CFU in different conditions.  240 
For the endometriotic stromal cells, the total CE was 0.01 ± 0.01% and significantly 241 
increased after macrophage co-culture (0.19 ± 0.04%, P<0.001) and macrophage CM 242 
(0.10 ± 0.04, P<0.05, Fig 2B). More large endometriotic stromal CFUs formed after 243 
co-culture with macrophage (0.14 ± 0.04%, P<0.001) and macrophage CM (0.05 ± 244 
0.03%, P<0.05) when compared with the control (0.0003 ± 0.003%). Endometriotic 245 
stromal small colonies also significantly increased when co-cultured with 246 
macrophages when compared with the control or the PMA group (P<0.05). 247 
 
 
Clonogenicity of Human Endometriotic Cells after Co-culture with Macrophages 248 
from Patients without Endometriosis 249 
We performed additional co-culture experiments to further investigate the interactions 250 
between macrophages and endometriotic cells. Endometriotic epithelial and stromal 251 
cells were co-cultured with non endometriotic macrophages and their CM. The CEs 252 
for endometriotic epithelial and stromal cells were similar for all the conditions (Fig 253 
3A, B). 254 
Invasion and Self-Renewal Ability of Endometrial and Endometriotic Cells after 255 
Co-culture with Autologous Macrophages 256 
There were no changes in the invasiveness of endometrial epithelial cells (Fig 1C). 257 
However, co-culture with macrophages or macrophage CM increased the invasion of 258 
endometrial stromal cells (P<0.05, Fig 1D). For endometriotic samples, the 259 
invasiveness of the epithelial cells increased after co-culture with macrophages 260 
(P<0.05, Fig 2C).  This stimulatory effect was also detected on endometriotic stromal 261 
cells after co-culture with macrophages and macrophage CM (P<0.05, Fig 2D).  262 
The self-renewal ability of cells in the large CFU after co-culture was assessed using a 263 
serial cloning strategy. We observed a decline in the number of self-renewal rounds in 264 
cells after co-culture when compared to the corresponding control (endometrial 265 
epithelial: 1.0 ± 0.1 vs 2.4 ± 0.1, Fig 1E; endometrial stromal: 2.0 ± 0.2 vs 4.0 ± 0.2, 266 
Fig 1F; endometriotic epithelial: 0.8 ± 0.3 vs 3.1 ± 0.1, Fig 2E; endometriotic stromal: 267 
1.1 ± 0.4 vs 3.9 ± 0.1; Fig 2F) though the differences were not yet significant.    268 
Since the self-renewal activity of stromal cells declined after macrophage co-culture, 269 
we examined the phenotypic expression of the endometrial stromal cells using the 270 
 
 
endometrial mesenchymal-like stem cell markers: CD140b and CD146.  Flow 271 
cytometry analysis of CD140b+CD146+ cells on clonally derived stromal cells after 272 
co-incubation with macrophages (3.12 ± 2.50%) and their CM (6.28 ± 5.0%) was not 273 
significantly different from the control (7.84 ± 3.5%, Supplementary data S3E). 274 
 275 
Cytokine Profile of Macrophages from Patients with and without Endometriosis 276 
The macrophage CM from patients with and without endometriosis were compared 277 
using a cytokine array for 42 cytokines (Supplementary table S1). Densitometric 278 
analysis revealed a 4-fold higher level of CSF-1 in the CM of endometriosis samples 279 
(1.11 ± 0.67) than in that of no endometriosis (0.25 ± 0.04, P<0.05, Fig 4A, B). 280 
Consistently, the amount of CSF-1 released into the CM from endometriotic 281 
macrophages was significantly higher (597 ± 140 pg/ml, n = 11) than that from 282 
normal endometrial macrophages (159 ± 40 pg/ml, P<0.05, Fig 4B) determined by 283 
ELISA. However, CSF-1 at concentrations of 30, 300 and 3000 pg/ml did not affect 284 
the total CEs of epithelial and stromal cells from endometrial (Fig 5A, C) and 285 
endometriotic tissues (Fig 6A, C). The different concentrations of CSF-1 did not 286 
affect the invasion ability of endometrial (Fig 5B, D) or endometriotic cells (Fig 6B, 287 
D). Although a decline trend in the CEs of endometrial cells were observed after 288 
neutralization with CSF-1 antibody, it did not reach statistic significance due to the 289 
small sample size (Supplementary data S4A, B).      290 
 291 
DISCUSSION 292 
 
 
Endometriosis is a multifactorial disease, and its etiology remains uncertain. Among 293 
the theories proposed to explain the pathogenesis of endometriosis, Sampson’s theory 294 
of retrograde menstruation is most widely accepted. In reproductive-age women, a 295 
reflux of menstrual tissue enters the peritoneal cavity and embeds into intra-296 
abdominal areas (27). Susceptibility to endometriosis is due to enhanced endometrial 297 
cell adhesion to the peritoneum and poor clearance of refluxed endometrial cells by 298 
the host immune response (28). Macrophage function is augmented in endometriotic 299 
lesions (14). Bacci et al. demonstrated a pro-inflammatory role for macrophages that 300 
exacerbates growth and vascularization of endometriotic lesions (29).  301 
In this study, the clonogenicity and invasiveness of endometriotic stromal cells 302 
increased significantly after co-cultured with autologous macrophages. Interestingly, 303 
the stimulatory effect was not observed when endometriotic stromal cells were co-304 
cultured with macrophages from patients without endometriosis. These observations 305 
suggest there may be a two-way communication between macrophages and the 306 
endometriotic stromal cells in regulating the proliferation and invasion activity of 307 
colony-forming cells. Macrophages can be stimulated by soluble factors derived from 308 
endometriotic cells and differentiate in response to the changing microenvironment. 309 
Thus, the communication between macrophages and endometriotic cells can facilitate 310 
the progression of the disease. 311 
Previously, we demonstrated the existence of colony-forming cells in human 312 
endometrium and endometriosis (4, 23). Endometrial and endometriotic cells from 313 
large CFUs display properties of somatic stem cells (23, 30). The cells in the large 314 
CFUs are heterogeneous, compromising stem cells and their differentiating progenies. 315 
Thus, the observed increase of large CFUs may not be due to an expansion of the 316 
number of stem cells but rather an expansion of their downstream progenitors or 317 
 
 
transit amplifying cells. This notion is supported by our finding that co-culture with 318 
autologous macrophages lowered the self-renewal ability of clonally derived 319 
endometrial and endometriotic cells in serial cloning assays. Furthermore, clonally 320 
derived stromal cells after co-culture with macrophage or CM displayed lower 321 
expression of the endometrial mesenchymal stem-like cell surface markers (CD140b 322 
and CD146). It is likely that macrophages enhanced the proliferation but readily 323 
exhausted the proliferative potential of progenitors/transit amplifying cells of large 324 
CFUs.  325 
We also examined the differences of cytokines derived from macrophages from 326 
women with and without endometriosis. Since endometrial macrophages have a role 327 
in tissue angiogenesis, tissue remodeling and immune defense, a major population of 328 
uterine tissue macrophages is alternatively activated (31). Alternatively activated 329 
macrophages are more abundant in patients with endometriosis (32) and exacerbate 330 
the growth and vascularization of endometriotic lesions (29). In this study, the 331 
macrophages from women with and without endometriosis were found to polarized 332 
towards the alternatively activated or M2 phenotype and endometriotic macrophages 333 
released more CSF-1, which has been associated with the early establishment of 334 
endometriotic lesions (33). The level of CSF-1 in the peritoneal fluid of patients with 335 
endometriosis is higher than those without (34). CSF-1 can also enhance the 336 
proliferation, attachment and invasion of endometrial cells base from in vitro and in 337 
vivo studies (35, 36). However, our results showed that CSF-1 alone did not affect the 338 
clonogenicity or invasion activity of endometrial or endometriotic cells. Therefore, 339 
the stimulatory activities of macrophages co-culture with endometrial and 340 
endometriotic cells could be mediated by one or a cocktail of regulators that were not 341 
determined in this study. In addition, it is worth noting that the endometrium would 342 
 
 
produce other factors that mediate endometrial macrophage differentiation, and our 343 
current in vitro model may therefore not fully represent the behavior of these 344 
macrophages. A limitation of this study was the source of the macrophage used. 345 
Peritoneal macrophages would undoubtedly provide a better insight into the peritoneal 346 
phenomenon on endometrial and endometriotic cells. However, to obtain sufficient 347 
amount of peritoneal macrophages would be difficult, hence we used peripheral 348 
monocyte derived macrophages. Other immune cells such as T cells within the 349 
endometrial leukocyte population can also promote the growth and invasion of 350 
endometriotic stromal cells (37).   351 
Currently, direct evidence supporting the involvement of endometrial stem/progenitor 352 
cells in the etiology of endometriosis is limited. While the existence of endometrial 353 
stem/progenitor cells in the endometrial basalis is well documented (38), some 354 
evidence supports the presence of endometrial stem/progenitor cells in endometriotic 355 
lesions (23, 39). There is also evidence that fragments of the shed endometrial basalis, 356 
likely containing endometrial stem/progenitor cells, are more often shed in the 357 
menstrual blood of women with endometriosis than in that of healthy control subjects 358 
(40, 41). Thus, when exposed to an environment conducive to the formation of 359 
endometriosis, such as the presence of dysregulated macrophages, the retrograded 360 
endometrial stem/progenitor cells differentiate and their progenies proliferate in 361 
ectopic sites, leading to the development of endometriotic lesions. However, whether 362 
the altered macrophage changes are primary or secondary occurrences remains 363 
uncertain.  364 
In conclusion, the evidence that co-culture of macrophages enhances the 365 
clonogenicity and invasion activity of endometriotic stromal cells suggests phagocytic 366 
cells and endometriotic cells may contribute to the committed progeny expansion of 367 
 
 
retrograde endometrial cells, giving rise to endometriosis.  Further work should be 368 
undertaken to identify the kinase signals involve in the cell communication between 369 
macrophages and endometriotic stromal cells, as these pathways may represent a 370 
target for endometriosis treatment. 371 
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FIGURE LEGENDS 387 
 
 
Figure 1 – Clonogenicity, invasion ability and self-renewal activity of 388 
endometrial epithelial and stromal cells with autologous macrophages. Cloning 389 
efficiency (CE) of (A) epithelial and (B) stromal cells after culture in PMA, co-culture 390 
macrophages (co-culture) and macrophage conditioned media (CM) for 15 days. Bars 391 
represent total CE (sum of small and large CFUs). White bars indicate large CFU; 392 
shaded bars indicate small CFUs. Relative cell invasion capacity of (C) epithelial and 393 
(D) stromal cells after culture in different conditions. Control was set as one. Self-394 
renewal activity of (E) epithelial and (F) stromal cells co-culture with macrophages. 395 
Results reported as means ± SEM; clonogenicity: epithelial n = 4, stromal n = 8; 396 
invasion: n = 4, self-renewal n=3. *, a,b,d,e P<0.05; **, c P<0.01; *** P<0.001. ***; a-c 397 
are significant differences for large CFUs, d-e are significant differences for small 398 
CFUs. CFU, colony-forming unit; CM, conditioned medium; PMA, phorbol-12 399 
myristate 13-acetate; SEM, standard error of the mean. 400 
Figure 2 – Clonogenicity, invasion ability and self-renewal activity of 401 
endometriotic epithelial and stromal cells with autologous macrophages. Cloning 402 
efficiency (CE) of (A) epithelial and (B) stromal cells after culture in PMA, co-culture 403 
macrophages (co-culture) and macrophage conditioned media (CM) for 15 days. Bars 404 
represent total CE (sum of small and large CFUs). White bars indicate large CFU; 405 
shaded bars indicate small CFUs. Relative cell invasion capacity of (C) epithelial and 406 
(D) stromal cells after culture in different conditions. Control was set as one. Self-407 
renewal activity of (E) epithelial and (F) stromal cells co-culture with macrophages. 408 
Results reported as means ± SEM; clonogenicity: epithelial n = 8, stromal n = 13; 409 
invasion: epithelial n = 3, stromal n = 4, self-renewal n = 3. *,a,c P<0.05;  ***,b 410 
P<0.001. a,b are significant differences for large CFUs, c are significant differences for 411 
 
 
small CFUs. CFU, colony-forming unit; SEM, CM, conditioned medium; PMA, 412 
phorbol-12 myristate 13-acetate; standard error of the mean. 413 
 414 
Figure 3 - The clonogenicity of endometriotic epithelial and stromal cells after 415 
co-culture with macrophages from patient without endometriosis. 416 
Cloning efficiency (CE) of (A) epithelial and (B) stromal cells after culture in PMA, 417 
co-culture macrophages (without endometriosis) and macrophage conditioned media 418 
(CM) for 15 days. Bars represent total CE (sum of small and large CFUs). White bars 419 
indicate large CFU; shaded bars indicate small CFUs. Results reported as means ± 420 
SEM; endometriotic epithelial and stromal cells n = 3. CM, conditioned medium; 421 
PMA, phorbol-12 myristate 13-acetate. 422 
 423 
Figure 4 – Identification of CSF-1 released by macrophages with and without 424 
endometriosis. Cytokine arrays of the expression of 42 human cytokines in the 425 
macrophage conditioned medium from women with and without endometriosis were 426 
evaluated.  (A) Representative images of the densitometry produced from the cytokine 427 
array.  (B) Arrays were visualized by enhanced luminal-based chemiluminescence and 428 
the dot intensities of CSF-1 were quantified by densitometry using Quantity One 429 
software. Each bar consists of relative expression (%) for no endometriosis (grey bar) 430 
and endometriosis (white bar) of macrophage conditioned medium, n = 6. (C) 431 
Histogram showing the amounts, in pg/mL, of the CSF-1 as quantified by ELISA, 432 
endometrium: n = 9; endometriosis: n = 11. Results reported as means ± SEM; * 433 
 
 
P<0.05. CSF-1, Colony Stimulating Factor-1; ELISA; enzyme-linked immunosorbent 434 
assay, SEM, standard error of the mean. 435 
 436 
Figure 5 – The clonogenicity and invasion activity of endometrial epithelial and 437 
stromal cells after CSF-1 treatment.  438 
Cloning efficiency (CE) of endometrial (A) epithelial and (C) stromal cells after 439 
treatment with different concentrations of CSF-1: 30, 300 and 3000 pg/ml for 15 days. 440 
Bars represent total CE (sum of small and large CFUs). Relative cell invasion 441 
capacity of epithelial (B) and stromal (D) cells after culture in different conditions. 442 
Control was set as one. Results reported as means ± SEM; endometrial epithelial and 443 
stromal cells n = 3. CFU, colony-forming unit; CSF-1, Colony Stimulating Factor-1; 444 
SEM, standard error of the mean. 445 
Figure 6 – The clonogenicity and invasion activity of endometriotic epithelial and 446 
stromal cells after CSF-1 treatment.  447 
Cloning efficiency (CE) of endometriotic (A) epithelial and (C) stromal cells after 448 
treatment with different concentrations of CSF-1: 30, 300 and 3000 pg/ml for 15 days. 449 
Bars represent total CE (sum of small and large CFUs). Relative cell invasion 450 
capacity of epithelial (B) and stromal (D) cells after culture in different conditions. 451 
Control was set as one. Results reported as means ± SEM; endometriotic epithelial 452 
cells (clonogenicity, n= 7; invasion, n = 3); endometriotic stromal cells (clonogenicity, 453 
n = 8; invasion, n=3). CFU, colony-forming unit; CSF-1, Colony Stimulating Factor-1; 454 
SEM, standard error of the mean. 455 
 456 
 
 
Supplementary Figure S1 – Induction of macrophage differentiation. (A) 457 
Monocytes isolated from peripheral blood mononuclear cells were incubated with 458 
phorbol myristate acetate (PMA, 50ng/ml) for 72 h to induce macrophage 459 
differentiation. Scale bar: 50 µM. (B) Representative histogram for FITC isotype and 460 
pan macrophage marker CD68-FITC conjugated. (C) The phenotypic expression of 461 
macrophages with (n = 3) and without endometriosis (n = 6). Percentage of 462 
macrophages expressing M1 marker - CD86 and M2 marker - CD206. Results 463 
reported as means ± SEM.  464 
Supplementary Figure S2 –Representative images of the endometrial stromal (A) 465 
CFUs formed and (B) invasion activity under control condition, PMA treatment, co-466 
culture with macrophage and macrophage CM. (C) Representative serially passaged 467 
images of the CFUs formed by endometrial stromal cells at different passages (P1 to 468 
P4).    469 
Supplementary Figure S3 – Gating strategy for co-expression of CD140b and 470 
CD146 on human endometrial stromal cells. (A) Clonally derived human 471 
endometrial stromal cells after 15 days in culture were analyzed by flow cytometry for 472 
expression of cell surface markers. Viable cells were selected by their forward scatter 473 
(FSC) and side scatter (SSC) profile. (B) Cell properties; SSC area (SSC-A) versus 474 
SSC height (SSC-H) to gate out cell doublets and aggregates to ensure the signal 475 
arises from single cell. (C) Single parameter histograms for individual markers 476 
CD146-FITC, CD140b-PE. Grey line indicates background fluorescence with isotype 477 
matched IgG control. (D) Representative dot pot of CD140b+CD146+ cells from 478 
endometrial stromal cells after co-cultured with macrophage. (E) Percentages of 479 
CD140b+CD146+ cells after culture in different conditions (n = 5). Results are 480 
reported as means ± SEM. 481 
 
 
Supplementary Figure S4 – The clonogenicity of endometrial epithelial and 482 
stromal cells after co-culture with autologous macrophages and treatment with 483 
CSF-1 neutralizing antibody. 484 
Cloning efficiency (CE) of (A) epithelial and (B) stromal cells after culture in PMA, 485 
co-culture macrophages (co-culture), co-culture with macrophages together with CSF-486 
1 antibody (co-culture + CSF-1 Ab), macrophage conditioned media (CM) and 487 
macrophage conditioned medium together with CSF-1 antibody (CM + CSF-1 Ab) for 488 
15 days. Bars represent total CE (sum of small and large CFUs). White bars indicate 489 
large CFU; shaded bars indicate small CFUs. Results reported as means ± SEM; 490 
epithelial and stromal cells n = 3. CSF-1, Colony Stimulating Factor-1; CM, 491 
conditioned medium; PMA, phorbol-12 myristate 13-acetate.  492 
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